Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

198.80INR
4 Sep 2015
Change (% chg)

Rs-9.10 (-4.38%)
Prev Close
Rs207.90
Open
Rs206.10
Day's High
Rs206.60
Day's Low
Rs195.60
Volume
39,951
Avg. Vol
106,777
52-wk High
Rs358.00
52-wk Low
Rs163.10

CLAI.BO

Chart for CLAI.BO

About

Claris Lifesciences Limited is an India-based holding company. The Company is engaged in drugs and pharmaceuticals. It is a holding company of Claris Injectables, a wholly owned subsidiary dealing in Specialty Injectables business, and Claris Otsuka, an associate of the Company dealing in intravenous nutrition products. Claris... (more)

Overall

Beta: 0.86
Market Cap(Mil.): Rs10,848.07
Shares Outstanding(Mil.): 54.57
Dividend: 9.00
Yield (%): 5.03

Financials

  CLAI.BO Industry Sector
P/E (TTM): 7.70 35.80 35.95
EPS (TTM): 25.83 -- --
ROI: -- 15.54 14.99
ROE: -- 16.12 15.87
Search Stocks

Cadila Healthcare near deal to buy smaller rival Claris - paper

MUMBAI - Cadila Healthcare Ltd, among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

India's Cadila Healthcare near deal to buy smaller rival Claris: paper

MUMBAI - Cadila Healthcare Ltd , among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

India's Cadila Healthcare near deal to buy smaller rival Claris - paper

MUMBAI, May 21 - Cadila Healthcare Ltd, among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

Earnings vs. Estimates

Search Stocks